LUND, Sweden, Jan. 3, 2018 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, announced today that a development milestone payment of USD 6 million has been triggered under the...
from PR Newswire: //www.prnewswire.co.uk/news-releases/alligator-bioscience-to-receive-usd-6-million-milestone-payment-from-janssen-coupled-to-the-decision-to-667840693.html
No comments:
Post a Comment